Gerd Döring
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gerd Döring has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Martina Ulrich
Institute of Medical Microbiology and Hygiene , Tübingen, Germany
6 shared publications- Alessandra Bragonzi
Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy
4 shared publications Alexa A. Pragman
Department of Microbiology, University of Minnesota Medical School, Minneapolis, MN, USA
2 shared publicationsAmbrose Cheung
Department of Microbiology and Immunology,Dartmouth Medical School, Hanover, NH, USA
2 shared publicationsChristoph Meisner
Institute for Medical Information Processing, Westbahnhofstrasse 55, 72074 Tübingen, Germany; and
2 shared publicationsDieter Worlitzsch
Institute of Medical Microbiology and Hygiene, Universitätsklinikum Tübingen, Wilhelmstrasse 31, 72074 Tübingen, Germany
2 shared publications
Latest Publications
- Top Cited Papers
- 1 December 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11 (6) , 461-479
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- 1 December 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11 (6) , 461-479
Top Cited PapersTreatment of lung infection in patients with cystic fibrosis: Current and future strategies
- Open Access
- 1 January 2011
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 35 (1) , 124-146
Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease
Cystic fibrosis (CF), the most common autosomal recessive disorder in Caucasians, and chronic obstructive pulmonary disease (COPD), a disease of adul
- 1 January 2011
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 35 (1) , 124-146
Open AccessDifferential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease
Cystic fibrosis (CF), the most common autosomal recessive disorder in Caucasians, and chronic obstructive pulmonary disease (COPD), a disease of adul
- 1 December 2010
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 300 (8) , 573-577
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
- 1 December 2010
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 300 (8) , 573-577
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
- Open Access
- 15 November 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (10) , 1585-1592
Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa
Background. Antibiotic combination therapy might be more efficient than single antibiotics to combat Pseudomonas aeruginosa biofilms in the airways o
- 15 November 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (10) , 1585-1592
Open AccessColistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa
Background. Antibiotic combination therapy might be more efficient than single antibiotics to combat Pseudomonas aeruginosa biofilms in the airways o
- Open Access
- 12 January 2009
- Published by Hindawi Limited in Cellular Microbiology
- Vol. 11 (2) , 208-216
Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease
Innate immunity is essential for prevention of infection in vertebrates and plants and dysfunction of single components of innate immunity may provoke severe disease. Here we describe how mutations in the cystic fibrosis transmembrane conductance regulator gene dysregulate a variety of components of the innate immune system in individuals suffering from the hereditary disease cystic fibrosis. In the airways of these individuals, functions of the mucociliary clearance system, cationic antimicrobial (poly)peptides and neutrophils and macrophages are impaired and inflammatory signal transduction pathways exaggerated. Consequently, chronic airway colonization with opportunistic bacterial pathogens develops and leads to life‐threatening lung disease.
- 12 January 2009
- Published by Hindawi Limited in Cellular Microbiology
- Vol. 11 (2) , 208-216
Open AccessCystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease
Innate immunity is essential for prevention of infection in vertebrates and plants and dysfunction of single components of innate immunity may provoke severe disease. Here we describe how mutations in the cystic fibrosis transmembrane conductance regulator gene dysregulate a variety of components of the innate immune system in individuals suffering from the hereditary disease cystic fibrosis. In the airways of these individuals, functions of the mucociliary clearance system, cationic antimicrobial (poly)peptides and neutrophils and macrophages are impaired and inflammatory signal transduction pathways exaggerated. Consequently, chronic airway colonization with opportunistic bacterial pathogens develops and leads to life‐threatening lung disease.
- Open Access
- 1 October 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (42) , 28629-28640
Post-translational Tyrosine Nitration of Eosinophil Granule Toxins Mediated by Eosinophil Peroxidase
- 1 October 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (42) , 28629-28640
Open AccessPost-translational Tyrosine Nitration of Eosinophil Granule Toxins Mediated by Eosinophil Peroxidase
- 1 January 2008
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 46 (7) , 909-18
Validation criteria for nucleic acid amplification techniques for bacterial infections
Nucleic acid techniques (NATs), such as species-specific and universal polymerase chain reactions (PCRs), are finding ever wider use in the diagnosis of bacterial infection. However, although universal PCR assays, in particular, approach a type of modern Petri dish, they have a number of limitations which restrict their applicability. The sensitivity of universal PCR is lower than that of many species-specific PCRs, and the contamination of samples and PCR reagents with irrelevant DNA from various sources remains a problem. Thus, NATs in general and universal PCR assays in particular require careful validation to be of value for the diagnosis of infection. Validation includes sampling, DNA extraction/isolation, template amplification and visualisation of the results. Furthermore, it implies the establishment of measures of asepsis, the inclusion of positive and negative controls, techniques to optimise the release of DNA from bacterial cells, adequate repetition of the amplification reaction, and routine testing of reagent negative and inhibition controls. Finally, it entails the comparison of results obtained by NATs with those obtained by conventional microbiological methods and matching with clinical evidence of infection. Validation of NATs in clinical diagnosis remains an ongoing challenge. Because of these limitations, NATs can only serve as adjunct tools for the diagnosis of infection in selected cases; they cannot replace conventional culturing techniques.
- 1 January 2008
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 46 (7) , 909-18
Validation criteria for nucleic acid amplification techniques for bacterial infections
Nucleic acid techniques (NATs), such as species-specific and universal polymerase chain reactions (PCRs), are finding ever wider use in the diagnosis of bacterial infection. However, although universal PCR assays, in particular, approach a type of modern Petri dish, they have a number of limitations which restrict their applicability. The sensitivity of universal PCR is lower than that of many species-specific PCRs, and the contamination of samples and PCR reagents with irrelevant DNA from various sources remains a problem. Thus, NATs in general and universal PCR assays in particular require careful validation to be of value for the diagnosis of infection. Validation includes sampling, DNA extraction/isolation, template amplification and visualisation of the results. Furthermore, it implies the establishment of measures of asepsis, the inclusion of positive and negative controls, techniques to optimise the release of DNA from bacterial cells, adequate repetition of the amplification reaction, and routine testing of reagent negative and inhibition controls. Finally, it entails the comparison of results obtained by NATs with those obtained by conventional microbiological methods and matching with clinical evidence of infection. Validation of NATs in clinical diagnosis remains an ongoing challenge. Because of these limitations, NATs can only serve as adjunct tools for the diagnosis of infection in selected cases; they cannot replace conventional culturing techniques.
- Open Access
- 14 September 2007
- Published by Wiley in Molecular Microbiology
- Vol. 66 (1) , 278
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions
- 14 September 2007
- Published by Wiley in Molecular Microbiology
- Vol. 66 (1) , 278
Open AccessThe staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions
- Open Access
- 3 August 2007
- Published by Wiley in Molecular Microbiology
- Vol. 65 (5) , 1276-1287
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions
Summary: In anaerobic environments, Staphylococcus aureus increases the transcription of the intercellular adhesin (ica) cluster, leading to increased polysaccharide intercellular adhesin (PIA) production. The regulatory mechanisms involved in this phenotypic change are mostly unknown. Here we show that the staphylococcal respiratory response regulator, SrrAB, significantly increases icaA transcription under anaerobic growth in S. aureus. Phosphorylated SrrA preferentially bound to a 100 bp DNA sequence located upstream of ica, and dot blot assays revealed little or no PIA expression in S. aureus srrAB deletion‐replacement mutants of strains Sa113 and SH1000, grown anaerobically. The biological relevance of SrrAB for S. aureus was assessed in a phagocytosis assay employing human neutrophils. Sixty‐eight per cent of PIA producing wild‐type cells, but only 19% of srrAB mutant cells survived under anaerobic conditions, suggesting that PIA protected S. aureus against non‐oxidative killing mechanisms of the neutrophils. No protection was observed when S. aureus or S. epidermidis strains, producing PIA also under aerobic conditions, were subjected to phagocytosis under aerobic conditions. These results demonstrate that SrrAB is a major activator of ica expression and PIA production in anaerobic environments, where it contributes to the protection of S. aureus against non‐oxidative defence mechanisms.
- 3 August 2007
- Published by Wiley in Molecular Microbiology
- Vol. 65 (5) , 1276-1287
Open AccessThe staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions
Summary: In anaerobic environments, Staphylococcus aureus increases the transcription of the intercellular adhesin (ica) cluster, leading to increased polysaccharide intercellular adhesin (PIA) production. The regulatory mechanisms involved in this phenotypic change are mostly unknown. Here we show that the staphylococcal respiratory response regulator, SrrAB, significantly increases icaA transcription under anaerobic growth in S. aureus. Phosphorylated SrrA preferentially bound to a 100 bp DNA sequence located upstream of ica, and dot blot assays revealed little or no PIA expression in S. aureus srrAB deletion‐replacement mutants of strains Sa113 and SH1000, grown anaerobically. The biological relevance of SrrAB for S. aureus was assessed in a phagocytosis assay employing human neutrophils. Sixty‐eight per cent of PIA producing wild‐type cells, but only 19% of srrAB mutant cells survived under anaerobic conditions, suggesting that PIA protected S. aureus against non‐oxidative killing mechanisms of the neutrophils. No protection was observed when S. aureus or S. epidermidis strains, producing PIA also under aerobic conditions, were subjected to phagocytosis under aerobic conditions. These results demonstrate that SrrAB is a major activator of ica expression and PIA production in anaerobic environments, where it contributes to the protection of S. aureus against non‐oxidative defence mechanisms.